Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Inclusion Criteria: * Patient diagnosed with moderate or severe exocrine pancreatic insufficiency (EPI), as defined using the Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) symptom score of 1.4 or greater. * Patient diagnosed with acute, recurrent acute pancreatitis or subacute pancreatitis. Subacute pancreatitis is defined as recent diagnosis of acute pancreatitis with sequelae of the acute episode including infection, pseudocyst, walled-off pancreatic necrosis. * Patient is currently admitted to the hospital at the time of study enrollment. * Patient requiring at least 50% of daily caloric and fluid intake through enteral tube feeds. * Patient is able and willing to provide informed consent. Exclusion Criteria: * Patient with chronic pancreatitis * Patient is currently intubated and unable to provide consent * Patient with active gastrointestinal tract cancer * Patient requiring less than 50% of nutritional support at time of enrollment * Patient is unable to tolerate any form of enteral nutrition